279 related articles for article (PubMed ID: 29358714)
1. Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks.
Reinhardt S; Stoye N; Luderer M; Kiefer F; Schmitt U; Lieb K; Endres K
Sci Rep; 2018 Jan; 8(1):1329. PubMed ID: 29358714
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor apicidin increases expression of the α-secretase ADAM10 through transcription factor USF1-mediated mechanisms.
Hu XT; Zhu BL; Zhao LG; Wang JW; Liu L; Lai YJ; He L; Deng XJ; Chen GJ
FASEB J; 2017 Apr; 31(4):1482-1493. PubMed ID: 28003340
[TBL] [Abstract][Full Text] [Related]
4. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease.
Pereira Vatanabe I; Peron R; Mantellatto Grigoli M; Pelucchi S; De Cesare G; Magalhães T; Manzine PR; Figueredo Balthazar ML; Di Luca M; Marcello E; Cominetti MR
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670873
[TBL] [Abstract][Full Text] [Related]
5. Tetraspanin 3: A central endocytic membrane component regulating the expression of ADAM10, presenilin and the amyloid precursor protein.
Seipold L; Damme M; Prox J; Rabe B; Kasparek P; Sedlacek R; Altmeppen H; Willem M; Boland B; Glatzel M; Saftig P
Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):217-230. PubMed ID: 27818272
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
Corbett GT; Gonzalez FJ; Pahan K
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
[TBL] [Abstract][Full Text] [Related]
7. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
Schroeder A; Fahrenholz F; Schmitt U
J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
[TBL] [Abstract][Full Text] [Related]
8. M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory.
Volmar CH; Salah-Uddin H; Janczura KJ; Halley P; Lambert G; Wodrich A; Manoah S; Patel NH; Sartor GC; Mehta N; Miles NTH; Desse S; Dorcius D; Cameron MD; Brothers SP; Wahlestedt C
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9135-E9144. PubMed ID: 29073110
[TBL] [Abstract][Full Text] [Related]
9. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
[TBL] [Abstract][Full Text] [Related]
10. Proteolytic cleavage of amyloid precursor protein by ADAM10 mediates proliferation and migration in breast cancer.
Tsang JYS; Lee MA; Chan TH; Li J; Ni YB; Shao Y; Chan SK; Cheungc SY; Lau KF; Tse GMK
EBioMedicine; 2018 Dec; 38():89-99. PubMed ID: 30470613
[TBL] [Abstract][Full Text] [Related]
11. [Effect of βsheet blocking peptide H102 on APP metabolic enzymes in hippocampal brain of double transgenic AD mice].
Jiang F; Sun FX; Xu SM
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):299-303. PubMed ID: 29926633
[TBL] [Abstract][Full Text] [Related]
12. Quercetin stimulates the non-amyloidogenic pathway via activation of ADAM10 and ADAM17 gene expression in aluminum chloride-induced Alzheimer's disease rat model.
Elfiky AM; Mahmoud AA; Elreedy HA; Ibrahim KS; Ghazy MA
Life Sci; 2021 Nov; 285():119964. PubMed ID: 34537230
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
Shackleton B; Crawford F; Bachmeier C
Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
[TBL] [Abstract][Full Text] [Related]
14. Acitretin, an enhancer of alpha-secretase expression, crosses the blood-brain barrier and is not eliminated by P-glycoprotein.
Holthoewer D; Endres K; Schuck F; Hiemke C; Schmitt U; Fahrenholz F
Neurodegener Dis; 2012; 10(1-4):224-8. PubMed ID: 22301853
[TBL] [Abstract][Full Text] [Related]
15. ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker.
Manzine PR; Ettcheto M; Cano A; Busquets O; Marcello E; Pelucchi S; Di Luca M; Endres K; Olloquequi J; Camins A; Cominetti MR
Biomed Pharmacother; 2019 May; 113():108661. PubMed ID: 30836275
[TBL] [Abstract][Full Text] [Related]
16. Insulin-Like Growth Factor-1 Alleviates Expression of Aβ
Song F; Liu T; Meng S; Li F; Zhang Y; Jiang L
J Mol Neurosci; 2018 Dec; 66(4):595-603. PubMed ID: 30414017
[TBL] [Abstract][Full Text] [Related]
17. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
[TBL] [Abstract][Full Text] [Related]
18. Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer's disease.
Singh BK; Vatsa N; Kumar V; Shekhar S; Sharma A; Jana NR
Hum Mol Genet; 2017 Oct; 26(20):4042-4054. PubMed ID: 29016862
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of APP, ADAM10 and ADAM17 in the denervated mouse dentate gyrus.
Del Turco D; Schlaudraff J; Bonin M; Deller T
PLoS One; 2014; 9(1):e84962. PubMed ID: 24404197
[TBL] [Abstract][Full Text] [Related]
20. α-secretase ADAM10 physically interacts with β-secretase BACE1 in neurons and regulates CHL1 proteolysis.
Wang X; Wang C; Pei G
J Mol Cell Biol; 2018 Oct; 10(5):411-422. PubMed ID: 29325091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
